Long-term treatment with secukinumab led to sustained clinical improvement and normalization of inflammatory markers in patients with psoriasis Meeting Abstract

publication date

  • December 1, 2020

webpage

published in

start page

  • AB37

end page

  • AB37

volume

  • 83

issue

  • 6